Review



cell surface expression level  (Proteintech)


Bioz Verified Symbol Proteintech is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Proteintech cell surface expression level
    BTN3A2 inhibited SARS-CoV-2 entry and interacted with Spike protein via its RBD . a : Stable <t>expression</t> of BTN3A2 suppressed SARS-CoV-2 attachment to the <t>cell.</t> Huh7 cells overexpressing BTN3A2-L (BTN3A2-L Huh7) or BTN3A2-S (BTN3A2-S Huh7) and the control (Vector Huh7) cells were treated with DOX (1 μg/mL) for 24 h, then incubated with SARS-CoV-2 (MOI = 1) on ice at 4 °C for 1 h. Cells were washed by PBS three times and harvested to measure viral RNA copies based on SARS-CoV-2 N gene <t>level.</t> b : Representative immunofluorescence images of cell–cell fusion assay showing no apparent effect of BTN3A2 overexpression (BTN3A2-L and BTN3A2-S) on syncytia formation mediated by Spike of Delta. The HEK293T cells were transfected with Spike of Delta expression vector, and the Huh7 cells were transfected with px-300 for 16 h. The transfected Huh7 and HEK293T cells were co-cultured for 20 h and harvested for immunofluorescence assays. Scale bar, 10 μm. c : BTN3A2 interacted with the SARS-CoV-2 Spike protein. HEK293T cells (1 × 10 7 ) were co-transfected with expression vector of BTN3A2 isoform (BTN3A2-L-His or BTN3A2-S-His, each 5 μg) and Spike protein (5 μg) for 48 h. Whole-cell lysates were immunoprecipitated (IP) using anti-His antibody. Immunoblotting (IB) for His (BTN3A2-L-His or BTN3A2-S-His), Spike, and Tubulin was performed using anti-His, anti-Spike, and anti-Tubulin antibodies, respectively. d : BTN3A2-L interacted with the S1 subunit but not the S2 subunit of Spike protein. Spike S1 and S2 subunits were Flag-tagged. e : Endogenous BTN3A2 interacted with the Spike S1 protein. Huh7 cells (1 × 10 8 ) were transfected with expression vector for Spike S1 protein (S1-Flag, 20 μg) or empty vector (Vector) for 36 h, then cells were treated with or without IFN-α (450 U) for 12 h. Whole-cell lysates were immunoprecipitated (IP) using anti-Flag antibody. Immunoblotting (IB) for BTN3A2, Flag (S1-Flag), and Tubulin was performed using anti- BTN3A2, anti-Flag, and anti-Tubulin antibodies, respectively. f-g : Biolayer interferometry analyses of Spike S1 protein binding to immobilized BTN3A2-L-His ( f ) and BTN3A2-S-His ( g ). Different concentrations (1 000, 500, 250, and 125 nM, corresponding to kinetic curves from top to bottom) of Spike S1 protein were used for binding to BTN3A2-L-His and BTN3A2-S-His (lacked 125 nM), respectively. h : BTN3A2-S interacted with the Flag-tagged S1 subunit of the Spike protein. i : BTN3A2 interacted with Spike RBDs of different SARS-CoV-2 variants. Procedures for IP and IB in ( d ), ( h ) and ( i ) are the same as those in ( c ). Data are representative of three independent experiments with similar results ( b – i ). ( a ) Values were presented as mean ± SD, and differences between groups were determined by comparing to the Dox-group; ANOVA with Dunnett's multiple comparisons, ∗∗∗, P < 0.001.
    Cell Surface Expression Level, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 2375 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cell+surface+expression+level/CEL+Antibody/pmc11367481-111-3-68
    Average 96 stars, based on 2375 article reviews
    cell surface expression level - by Bioz Stars, 2026-11
    96/100 stars

    Images

    1) Product Images from "Primate-specific BTN3A2 protects against SARS-CoV-2 infection by interacting with and reducing ACE2"

    Article Title: Primate-specific BTN3A2 protects against SARS-CoV-2 infection by interacting with and reducing ACE2

    Journal: eBioMedicine

    doi: 10.1016/j.ebiom.2024.105281

    BTN3A2 inhibited SARS-CoV-2 entry and interacted with Spike protein via its RBD . a : Stable expression of BTN3A2 suppressed SARS-CoV-2 attachment to the cell. Huh7 cells overexpressing BTN3A2-L (BTN3A2-L Huh7) or BTN3A2-S (BTN3A2-S Huh7) and the control (Vector Huh7) cells were treated with DOX (1 μg/mL) for 24 h, then incubated with SARS-CoV-2 (MOI = 1) on ice at 4 °C for 1 h. Cells were washed by PBS three times and harvested to measure viral RNA copies based on SARS-CoV-2 N gene level. b : Representative immunofluorescence images of cell–cell fusion assay showing no apparent effect of BTN3A2 overexpression (BTN3A2-L and BTN3A2-S) on syncytia formation mediated by Spike of Delta. The HEK293T cells were transfected with Spike of Delta expression vector, and the Huh7 cells were transfected with px-300 for 16 h. The transfected Huh7 and HEK293T cells were co-cultured for 20 h and harvested for immunofluorescence assays. Scale bar, 10 μm. c : BTN3A2 interacted with the SARS-CoV-2 Spike protein. HEK293T cells (1 × 10 7 ) were co-transfected with expression vector of BTN3A2 isoform (BTN3A2-L-His or BTN3A2-S-His, each 5 μg) and Spike protein (5 μg) for 48 h. Whole-cell lysates were immunoprecipitated (IP) using anti-His antibody. Immunoblotting (IB) for His (BTN3A2-L-His or BTN3A2-S-His), Spike, and Tubulin was performed using anti-His, anti-Spike, and anti-Tubulin antibodies, respectively. d : BTN3A2-L interacted with the S1 subunit but not the S2 subunit of Spike protein. Spike S1 and S2 subunits were Flag-tagged. e : Endogenous BTN3A2 interacted with the Spike S1 protein. Huh7 cells (1 × 10 8 ) were transfected with expression vector for Spike S1 protein (S1-Flag, 20 μg) or empty vector (Vector) for 36 h, then cells were treated with or without IFN-α (450 U) for 12 h. Whole-cell lysates were immunoprecipitated (IP) using anti-Flag antibody. Immunoblotting (IB) for BTN3A2, Flag (S1-Flag), and Tubulin was performed using anti- BTN3A2, anti-Flag, and anti-Tubulin antibodies, respectively. f-g : Biolayer interferometry analyses of Spike S1 protein binding to immobilized BTN3A2-L-His ( f ) and BTN3A2-S-His ( g ). Different concentrations (1 000, 500, 250, and 125 nM, corresponding to kinetic curves from top to bottom) of Spike S1 protein were used for binding to BTN3A2-L-His and BTN3A2-S-His (lacked 125 nM), respectively. h : BTN3A2-S interacted with the Flag-tagged S1 subunit of the Spike protein. i : BTN3A2 interacted with Spike RBDs of different SARS-CoV-2 variants. Procedures for IP and IB in ( d ), ( h ) and ( i ) are the same as those in ( c ). Data are representative of three independent experiments with similar results ( b – i ). ( a ) Values were presented as mean ± SD, and differences between groups were determined by comparing to the Dox-group; ANOVA with Dunnett's multiple comparisons, ∗∗∗, P < 0.001.
    Figure Legend Snippet: BTN3A2 inhibited SARS-CoV-2 entry and interacted with Spike protein via its RBD . a : Stable expression of BTN3A2 suppressed SARS-CoV-2 attachment to the cell. Huh7 cells overexpressing BTN3A2-L (BTN3A2-L Huh7) or BTN3A2-S (BTN3A2-S Huh7) and the control (Vector Huh7) cells were treated with DOX (1 μg/mL) for 24 h, then incubated with SARS-CoV-2 (MOI = 1) on ice at 4 °C for 1 h. Cells were washed by PBS three times and harvested to measure viral RNA copies based on SARS-CoV-2 N gene level. b : Representative immunofluorescence images of cell–cell fusion assay showing no apparent effect of BTN3A2 overexpression (BTN3A2-L and BTN3A2-S) on syncytia formation mediated by Spike of Delta. The HEK293T cells were transfected with Spike of Delta expression vector, and the Huh7 cells were transfected with px-300 for 16 h. The transfected Huh7 and HEK293T cells were co-cultured for 20 h and harvested for immunofluorescence assays. Scale bar, 10 μm. c : BTN3A2 interacted with the SARS-CoV-2 Spike protein. HEK293T cells (1 × 10 7 ) were co-transfected with expression vector of BTN3A2 isoform (BTN3A2-L-His or BTN3A2-S-His, each 5 μg) and Spike protein (5 μg) for 48 h. Whole-cell lysates were immunoprecipitated (IP) using anti-His antibody. Immunoblotting (IB) for His (BTN3A2-L-His or BTN3A2-S-His), Spike, and Tubulin was performed using anti-His, anti-Spike, and anti-Tubulin antibodies, respectively. d : BTN3A2-L interacted with the S1 subunit but not the S2 subunit of Spike protein. Spike S1 and S2 subunits were Flag-tagged. e : Endogenous BTN3A2 interacted with the Spike S1 protein. Huh7 cells (1 × 10 8 ) were transfected with expression vector for Spike S1 protein (S1-Flag, 20 μg) or empty vector (Vector) for 36 h, then cells were treated with or without IFN-α (450 U) for 12 h. Whole-cell lysates were immunoprecipitated (IP) using anti-Flag antibody. Immunoblotting (IB) for BTN3A2, Flag (S1-Flag), and Tubulin was performed using anti- BTN3A2, anti-Flag, and anti-Tubulin antibodies, respectively. f-g : Biolayer interferometry analyses of Spike S1 protein binding to immobilized BTN3A2-L-His ( f ) and BTN3A2-S-His ( g ). Different concentrations (1 000, 500, 250, and 125 nM, corresponding to kinetic curves from top to bottom) of Spike S1 protein were used for binding to BTN3A2-L-His and BTN3A2-S-His (lacked 125 nM), respectively. h : BTN3A2-S interacted with the Flag-tagged S1 subunit of the Spike protein. i : BTN3A2 interacted with Spike RBDs of different SARS-CoV-2 variants. Procedures for IP and IB in ( d ), ( h ) and ( i ) are the same as those in ( c ). Data are representative of three independent experiments with similar results ( b – i ). ( a ) Values were presented as mean ± SD, and differences between groups were determined by comparing to the Dox-group; ANOVA with Dunnett's multiple comparisons, ∗∗∗, P < 0.001.

    Techniques Used: Expressing, Control, Plasmid Preparation, Incubation, Immunofluorescence, Cell-Cell Fusion Assay, Over Expression, Transfection, Cell Culture, Immunoprecipitation, Western Blot, Protein Binding, Binding Assay

    BTN3A2 inhibited ACE2 expression . a : Differential expression of BTN3A2 and ACE2 in scRNA-seq dataset of lung tissues from COVID-19 patients and uninfected individuals. Original dataset was reported in Melms et al. Significance was assessed by two-sided Wilcox rank sum test. b : Stable expression of BTN3A2 decreased ACE2 mRNA level in Huh7 cells. RNA was extracted from Huh7 cells overexpressing BTN3A2-L and BTN3A2-S, or control (Vector Huh7) cells (each group 1 × 10 5 cells). BTN3A2 and ACE2 mRNA levels were measured by qRT-PCR, with normalization to GAPDH . c-d : Overexpression of BTN3A2-L ( c ) and BTN3A2-S ( d ) suppressed ACE2 protein expression in HEK293T cells. Cells (5 × 10 5 ) were transfected with indicated expression vector or empty vector (each 1.25 μg) for 48 h, then harvested for western blotting. e : Dose-dependent inhibitory effect of BTN3A2-L on ACE2 protein expression. HEK293T cells (5 × 10 5 ) were transfected with indicated expression vector or empty vector (each 0.5 μg), together with increased BTN3A2-L-His (0.25, 0.50, 0.75, and 1.50 μg, with empty vector to reach a total amount of 2.5 μg of plasmid) for 48 h, then harvested for western blotting. f : Knockout of BTN3A2 increased ACE2 mRNA level in Huh7 cells. The procedure was similar to that in (b). g : Knockout of BTN3A2 promoted ACE2 protein expression in Huh7 ( upper ) and Calu-3 ( lower ) cells. h-i : Flow cytometry was conducted to show surface ACE2 in Calu-3 cells with BTN3A2 overexpression (BTN3A2-L and BTN3A2-S) or knockout (sgBTN3A2-1 and sgBTN3A2-2), together with the control cells (vector and sgNC) and unstained cells. Cell surface expression of ACE2 was measured ( h ), and quantification of mean fluorescence intensity (MFI (%), n = 3) was based on three independent experiments ( i ). j : ACE2 in BTN3A2-tg and WT mice infected with indicated AAV-GFP and AAV-hACE2. Immunoblotting for ACE2, BTN3A2, GFP, and Tubulin was performed using anti-ACE2, anti-BTN3A2, anti-GFP, and anti-Tubulin antibodies, respectively. k : Representative images of immunohistochemical staining of ACE2 and BTN3A2 in lung tissues in ( j ). Scale bar, 100 μm. Data were representative of three independent experiments with similar results ( b-k ). Values were presented as mean ± SD ( b , f , and i ). Significance was determined compared to Vector ( b and i ) or sgNC ( f and i ). ns, not significant; ∗, P < 0.05; ∗∗, P < 0.01; ANOVA with Dunnett's multiple comparisons.
    Figure Legend Snippet: BTN3A2 inhibited ACE2 expression . a : Differential expression of BTN3A2 and ACE2 in scRNA-seq dataset of lung tissues from COVID-19 patients and uninfected individuals. Original dataset was reported in Melms et al. Significance was assessed by two-sided Wilcox rank sum test. b : Stable expression of BTN3A2 decreased ACE2 mRNA level in Huh7 cells. RNA was extracted from Huh7 cells overexpressing BTN3A2-L and BTN3A2-S, or control (Vector Huh7) cells (each group 1 × 10 5 cells). BTN3A2 and ACE2 mRNA levels were measured by qRT-PCR, with normalization to GAPDH . c-d : Overexpression of BTN3A2-L ( c ) and BTN3A2-S ( d ) suppressed ACE2 protein expression in HEK293T cells. Cells (5 × 10 5 ) were transfected with indicated expression vector or empty vector (each 1.25 μg) for 48 h, then harvested for western blotting. e : Dose-dependent inhibitory effect of BTN3A2-L on ACE2 protein expression. HEK293T cells (5 × 10 5 ) were transfected with indicated expression vector or empty vector (each 0.5 μg), together with increased BTN3A2-L-His (0.25, 0.50, 0.75, and 1.50 μg, with empty vector to reach a total amount of 2.5 μg of plasmid) for 48 h, then harvested for western blotting. f : Knockout of BTN3A2 increased ACE2 mRNA level in Huh7 cells. The procedure was similar to that in (b). g : Knockout of BTN3A2 promoted ACE2 protein expression in Huh7 ( upper ) and Calu-3 ( lower ) cells. h-i : Flow cytometry was conducted to show surface ACE2 in Calu-3 cells with BTN3A2 overexpression (BTN3A2-L and BTN3A2-S) or knockout (sgBTN3A2-1 and sgBTN3A2-2), together with the control cells (vector and sgNC) and unstained cells. Cell surface expression of ACE2 was measured ( h ), and quantification of mean fluorescence intensity (MFI (%), n = 3) was based on three independent experiments ( i ). j : ACE2 in BTN3A2-tg and WT mice infected with indicated AAV-GFP and AAV-hACE2. Immunoblotting for ACE2, BTN3A2, GFP, and Tubulin was performed using anti-ACE2, anti-BTN3A2, anti-GFP, and anti-Tubulin antibodies, respectively. k : Representative images of immunohistochemical staining of ACE2 and BTN3A2 in lung tissues in ( j ). Scale bar, 100 μm. Data were representative of three independent experiments with similar results ( b-k ). Values were presented as mean ± SD ( b , f , and i ). Significance was determined compared to Vector ( b and i ) or sgNC ( f and i ). ns, not significant; ∗, P < 0.05; ∗∗, P < 0.01; ANOVA with Dunnett's multiple comparisons.

    Techniques Used: Expressing, Control, Plasmid Preparation, Quantitative RT-PCR, Over Expression, Transfection, Western Blot, Knock-Out, Flow Cytometry, Fluorescence, Infection, Immunohistochemical staining, Staining

    Related Articles

    Incubation:

    Article Title: Monochromatic light affects intestinal barrier function of chick via an anti-oxidation pathway involving melatonin and its receptor Mel1b
    Article Snippet: .. Paraffin jejunal sections were incubated with primary antibodies at 4°C overnight: proliferating cell nuclear antigen (PCNA, 1:300; Proteintech, Wuhan, China), IgA (1:300; Abcam, Cambridge, England), Mel 1a (1:200; Abmart, Shanghai, China), Mel 1b (1:300; Abcam, USA) and Mel 1c (1:100; Abmart, Shanghai, China). .. Then, the sections were rinsed with PBS (0.01 M, pH = 7.4) and incubated with biotinylated secondary antibodies (Goat-anti-Mouse/Goat-anti-Rabbit, 1:300, CWBio, Taizhou, China) and streptavidin-horseradish peroxidase (1:300, Vector Laboratories, Burlingame, CA, USA) successively for 2 h at room temperature.

    Article Title: A paracrine-to-autocrine shunt of GREM1 fuels colorectal cancer metastasis via ACVR1C.
    Article Snippet: .. Subsequently, the samples were incubated with goat anti-GREM1 (3 μg/mL, R&D, AF956), mouse anti-β-Catenin (1:100, BD, 610154), rabbit anti-β-Catenin (1:100, Absea, RC-6352), rabbit anti-Vimentin (1:100, CST, 5741), rabbit anti-CD68 (1:100, CST, 26042), rabbit anti-FAP (1:50, Proteintech, 15384-1-AP), rabbit anti-α-SMA (1:100, Abcam, ab5694), rabbit anti-E-Cadherin (1:200, CST, 3195), rabbit antiACVR1C (1:50, Thermo, PA587475), rabbit anti-Snail (1:200, Abcam, ab224731) and mouse anti-CDX2 (1:200, Servicebio, GB151501) overnight at 4 °C. .. The tissues were incubated with Alexa-Fluor-conjugated secondary antibodies (Invitrogen) in AR TIC LE IN PR ES S PBS with 1 % normal donkey serum for 1 h at room temperature.

    Article Title: Remote Pancreatic Response to Severe Polytrauma Correlates With Clinical Outcome
    Article Snippet: After UV activation using a Chemidoc XRS+ (Biorad), proteins were blotted onto a PVDF membrane and total lane protein was measured using the Chemidoc imager. .. Membranes were blocked with 5% BSA in 0.1% Tween20 (Sigma, Taufkirchen, Germany) in TBS (TBS‐T) for 1 h at 4°C, and incubated with anti‐Cel (Proteintech, 15384‐1‐AP, 1:2000) and anti‐Pnlip (Proteintech, 11209‐1‐AP, 1:2000) antibodies o/n at 4°C. .. After washing three times with TBS‐T, 1:5000 ECL anti‐rabbit horseradish peroxidase (HRP) IgG secondary antibody (GE Healthcare, Duesseldorf, Germany) was added for 1 h at RT.

    other:

    Article Title: The sphingolipid metabolite sphingosine protects against hypertension by targeting metabolic-inflammatory crosstalk via the NLRP3 inflammasome
    Article Snippet: To use the Eastep Super Total RNA Extraction Kit (Promega, Shanghai, Cat# LS1040), extracted total RNA from homogenized HUVECs and RT-qPCR was performed as described in s ection 1.3.6.

    Article Title: Islet regeneration protein Reg3g promotes macrophage clearance of β cell-derived dysfunctional mitochondria-rich vesicles to mitigate T2DM
    Article Snippet: The single-cell suspensions were incubated for 45 min at 4 °C with the antibodies, including FITC-F4/80, PE-F4/80, FITC-CD11c, APC-CD206, APC-CD11b, which were manufactured by BD Biosciences.

    Article Title: TLR2-PI3K/Akt mediated microbe-mimetic priming boosts the therapeutic paracrine function of GelMA-Encapsulated MSCs for diabetic wound regeneration
    Article Snippet: After being centrifuged, quantified and denatured, 80 μg protein samples were separated by 12 % sodium dodecyl sulfate polyacrylamide gel electrophoresis and were then transferred onto methanol-activated polyvinylidene difluoride membranes (GE Healthcare, USA).

    Transcranial Magnetic Stimulation:

    Article Title: Remote Pancreatic Response to Severe Polytrauma Correlates With Clinical Outcome
    Article Snippet: After UV activation using a Chemidoc XRS+ (Biorad), proteins were blotted onto a PVDF membrane and total lane protein was measured using the Chemidoc imager. .. Membranes were blocked with 5% BSA in 0.1% Tween20 (Sigma, Taufkirchen, Germany) in TBS (TBS‐T) for 1 h at 4°C, and incubated with anti‐Cel (Proteintech, 15384‐1‐AP, 1:2000) and anti‐Pnlip (Proteintech, 11209‐1‐AP, 1:2000) antibodies o/n at 4°C. .. After washing three times with TBS‐T, 1:5000 ECL anti‐rabbit horseradish peroxidase (HRP) IgG secondary antibody (GE Healthcare, Duesseldorf, Germany) was added for 1 h at RT.

    Analysis:

    Article Title: E2F1 K117 methylation by SETD6 disrupts BRD4–E2F1 binding and modulates E2F1 chromatin binding and gene regulation in prostate cancer cells
    Article Snippet: Next, cells were washed with 1× Phosphate Buffered Saline (PBS) buffer (Gibco) and harvested by centrifugation at 500 g for 5 min. After harvesting, the amount of proteins in whole cell lysate was determined by western-blot. .. For protein/protein interaction analysis, the GFP-fused proteins were purified from the cell extract using GFP-trap A beads (Chromotek) according to the manufacturer’s instructions. ..

    Purification:

    Article Title: E2F1 K117 methylation by SETD6 disrupts BRD4–E2F1 binding and modulates E2F1 chromatin binding and gene regulation in prostate cancer cells
    Article Snippet: Next, cells were washed with 1× Phosphate Buffered Saline (PBS) buffer (Gibco) and harvested by centrifugation at 500 g for 5 min. After harvesting, the amount of proteins in whole cell lysate was determined by western-blot. .. For protein/protein interaction analysis, the GFP-fused proteins were purified from the cell extract using GFP-trap A beads (Chromotek) according to the manufacturer’s instructions. ..



    Similar Products

    96
    Proteintech cell surface expression level
    BTN3A2 inhibited SARS-CoV-2 entry and interacted with Spike protein via its RBD . a : Stable <t>expression</t> of BTN3A2 suppressed SARS-CoV-2 attachment to the <t>cell.</t> Huh7 cells overexpressing BTN3A2-L (BTN3A2-L Huh7) or BTN3A2-S (BTN3A2-S Huh7) and the control (Vector Huh7) cells were treated with DOX (1 μg/mL) for 24 h, then incubated with SARS-CoV-2 (MOI = 1) on ice at 4 °C for 1 h. Cells were washed by PBS three times and harvested to measure viral RNA copies based on SARS-CoV-2 N gene <t>level.</t> b : Representative immunofluorescence images of cell–cell fusion assay showing no apparent effect of BTN3A2 overexpression (BTN3A2-L and BTN3A2-S) on syncytia formation mediated by Spike of Delta. The HEK293T cells were transfected with Spike of Delta expression vector, and the Huh7 cells were transfected with px-300 for 16 h. The transfected Huh7 and HEK293T cells were co-cultured for 20 h and harvested for immunofluorescence assays. Scale bar, 10 μm. c : BTN3A2 interacted with the SARS-CoV-2 Spike protein. HEK293T cells (1 × 10 7 ) were co-transfected with expression vector of BTN3A2 isoform (BTN3A2-L-His or BTN3A2-S-His, each 5 μg) and Spike protein (5 μg) for 48 h. Whole-cell lysates were immunoprecipitated (IP) using anti-His antibody. Immunoblotting (IB) for His (BTN3A2-L-His or BTN3A2-S-His), Spike, and Tubulin was performed using anti-His, anti-Spike, and anti-Tubulin antibodies, respectively. d : BTN3A2-L interacted with the S1 subunit but not the S2 subunit of Spike protein. Spike S1 and S2 subunits were Flag-tagged. e : Endogenous BTN3A2 interacted with the Spike S1 protein. Huh7 cells (1 × 10 8 ) were transfected with expression vector for Spike S1 protein (S1-Flag, 20 μg) or empty vector (Vector) for 36 h, then cells were treated with or without IFN-α (450 U) for 12 h. Whole-cell lysates were immunoprecipitated (IP) using anti-Flag antibody. Immunoblotting (IB) for BTN3A2, Flag (S1-Flag), and Tubulin was performed using anti- BTN3A2, anti-Flag, and anti-Tubulin antibodies, respectively. f-g : Biolayer interferometry analyses of Spike S1 protein binding to immobilized BTN3A2-L-His ( f ) and BTN3A2-S-His ( g ). Different concentrations (1 000, 500, 250, and 125 nM, corresponding to kinetic curves from top to bottom) of Spike S1 protein were used for binding to BTN3A2-L-His and BTN3A2-S-His (lacked 125 nM), respectively. h : BTN3A2-S interacted with the Flag-tagged S1 subunit of the Spike protein. i : BTN3A2 interacted with Spike RBDs of different SARS-CoV-2 variants. Procedures for IP and IB in ( d ), ( h ) and ( i ) are the same as those in ( c ). Data are representative of three independent experiments with similar results ( b – i ). ( a ) Values were presented as mean ± SD, and differences between groups were determined by comparing to the Dox-group; ANOVA with Dunnett's multiple comparisons, ∗∗∗, P < 0.001.
    Cell Surface Expression Level, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cell+surface+expression+level/CEL+Antibody/pmc11367481-111-3-68
    Average 96 stars, based on 1 article reviews
    cell surface expression level - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    90
    Charles River Laboratories intact cos cells expressing high levels of rat recombinant pth receptors on the cell surface
    BTN3A2 inhibited SARS-CoV-2 entry and interacted with Spike protein via its RBD . a : Stable <t>expression</t> of BTN3A2 suppressed SARS-CoV-2 attachment to the <t>cell.</t> Huh7 cells overexpressing BTN3A2-L (BTN3A2-L Huh7) or BTN3A2-S (BTN3A2-S Huh7) and the control (Vector Huh7) cells were treated with DOX (1 μg/mL) for 24 h, then incubated with SARS-CoV-2 (MOI = 1) on ice at 4 °C for 1 h. Cells were washed by PBS three times and harvested to measure viral RNA copies based on SARS-CoV-2 N gene <t>level.</t> b : Representative immunofluorescence images of cell–cell fusion assay showing no apparent effect of BTN3A2 overexpression (BTN3A2-L and BTN3A2-S) on syncytia formation mediated by Spike of Delta. The HEK293T cells were transfected with Spike of Delta expression vector, and the Huh7 cells were transfected with px-300 for 16 h. The transfected Huh7 and HEK293T cells were co-cultured for 20 h and harvested for immunofluorescence assays. Scale bar, 10 μm. c : BTN3A2 interacted with the SARS-CoV-2 Spike protein. HEK293T cells (1 × 10 7 ) were co-transfected with expression vector of BTN3A2 isoform (BTN3A2-L-His or BTN3A2-S-His, each 5 μg) and Spike protein (5 μg) for 48 h. Whole-cell lysates were immunoprecipitated (IP) using anti-His antibody. Immunoblotting (IB) for His (BTN3A2-L-His or BTN3A2-S-His), Spike, and Tubulin was performed using anti-His, anti-Spike, and anti-Tubulin antibodies, respectively. d : BTN3A2-L interacted with the S1 subunit but not the S2 subunit of Spike protein. Spike S1 and S2 subunits were Flag-tagged. e : Endogenous BTN3A2 interacted with the Spike S1 protein. Huh7 cells (1 × 10 8 ) were transfected with expression vector for Spike S1 protein (S1-Flag, 20 μg) or empty vector (Vector) for 36 h, then cells were treated with or without IFN-α (450 U) for 12 h. Whole-cell lysates were immunoprecipitated (IP) using anti-Flag antibody. Immunoblotting (IB) for BTN3A2, Flag (S1-Flag), and Tubulin was performed using anti- BTN3A2, anti-Flag, and anti-Tubulin antibodies, respectively. f-g : Biolayer interferometry analyses of Spike S1 protein binding to immobilized BTN3A2-L-His ( f ) and BTN3A2-S-His ( g ). Different concentrations (1 000, 500, 250, and 125 nM, corresponding to kinetic curves from top to bottom) of Spike S1 protein were used for binding to BTN3A2-L-His and BTN3A2-S-His (lacked 125 nM), respectively. h : BTN3A2-S interacted with the Flag-tagged S1 subunit of the Spike protein. i : BTN3A2 interacted with Spike RBDs of different SARS-CoV-2 variants. Procedures for IP and IB in ( d ), ( h ) and ( i ) are the same as those in ( c ). Data are representative of three independent experiments with similar results ( b – i ). ( a ) Values were presented as mean ± SD, and differences between groups were determined by comparing to the Dox-group; ANOVA with Dunnett's multiple comparisons, ∗∗∗, P < 0.001.
    Intact Cos Cells Expressing High Levels Of Rat Recombinant Pth Receptors On The Cell Surface, supplied by Charles River Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cell+surface+expression+level/intact+cos+cells+expressing+high+levels+of+rat+recombinant+pth+receptors+on+the+cell+surface/us07150974-378-29-38
    Average 90 stars, based on 1 article reviews
    intact cos cells expressing high levels of rat recombinant pth receptors on the cell surface - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    National Institute of Standards and Technology cell lines with known levels of cell surface her-2/neu receptor expression
    BTN3A2 inhibited SARS-CoV-2 entry and interacted with Spike protein via its RBD . a : Stable <t>expression</t> of BTN3A2 suppressed SARS-CoV-2 attachment to the <t>cell.</t> Huh7 cells overexpressing BTN3A2-L (BTN3A2-L Huh7) or BTN3A2-S (BTN3A2-S Huh7) and the control (Vector Huh7) cells were treated with DOX (1 μg/mL) for 24 h, then incubated with SARS-CoV-2 (MOI = 1) on ice at 4 °C for 1 h. Cells were washed by PBS three times and harvested to measure viral RNA copies based on SARS-CoV-2 N gene <t>level.</t> b : Representative immunofluorescence images of cell–cell fusion assay showing no apparent effect of BTN3A2 overexpression (BTN3A2-L and BTN3A2-S) on syncytia formation mediated by Spike of Delta. The HEK293T cells were transfected with Spike of Delta expression vector, and the Huh7 cells were transfected with px-300 for 16 h. The transfected Huh7 and HEK293T cells were co-cultured for 20 h and harvested for immunofluorescence assays. Scale bar, 10 μm. c : BTN3A2 interacted with the SARS-CoV-2 Spike protein. HEK293T cells (1 × 10 7 ) were co-transfected with expression vector of BTN3A2 isoform (BTN3A2-L-His or BTN3A2-S-His, each 5 μg) and Spike protein (5 μg) for 48 h. Whole-cell lysates were immunoprecipitated (IP) using anti-His antibody. Immunoblotting (IB) for His (BTN3A2-L-His or BTN3A2-S-His), Spike, and Tubulin was performed using anti-His, anti-Spike, and anti-Tubulin antibodies, respectively. d : BTN3A2-L interacted with the S1 subunit but not the S2 subunit of Spike protein. Spike S1 and S2 subunits were Flag-tagged. e : Endogenous BTN3A2 interacted with the Spike S1 protein. Huh7 cells (1 × 10 8 ) were transfected with expression vector for Spike S1 protein (S1-Flag, 20 μg) or empty vector (Vector) for 36 h, then cells were treated with or without IFN-α (450 U) for 12 h. Whole-cell lysates were immunoprecipitated (IP) using anti-Flag antibody. Immunoblotting (IB) for BTN3A2, Flag (S1-Flag), and Tubulin was performed using anti- BTN3A2, anti-Flag, and anti-Tubulin antibodies, respectively. f-g : Biolayer interferometry analyses of Spike S1 protein binding to immobilized BTN3A2-L-His ( f ) and BTN3A2-S-His ( g ). Different concentrations (1 000, 500, 250, and 125 nM, corresponding to kinetic curves from top to bottom) of Spike S1 protein were used for binding to BTN3A2-L-His and BTN3A2-S-His (lacked 125 nM), respectively. h : BTN3A2-S interacted with the Flag-tagged S1 subunit of the Spike protein. i : BTN3A2 interacted with Spike RBDs of different SARS-CoV-2 variants. Procedures for IP and IB in ( d ), ( h ) and ( i ) are the same as those in ( c ). Data are representative of three independent experiments with similar results ( b – i ). ( a ) Values were presented as mean ± SD, and differences between groups were determined by comparing to the Dox-group; ANOVA with Dunnett's multiple comparisons, ∗∗∗, P < 0.001.
    Cell Lines With Known Levels Of Cell Surface Her 2/Neu Receptor Expression, supplied by National Institute of Standards and Technology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cell+surface+expression+level/her2+positive+standard+reference+materials+srm2373/10__1309_slash_e9b55jyhd84l8y17-98-14-26
    Average 90 stars, based on 1 article reviews
    cell lines with known levels of cell surface her-2/neu receptor expression - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    Image Search Results


    BTN3A2 inhibited SARS-CoV-2 entry and interacted with Spike protein via its RBD . a : Stable expression of BTN3A2 suppressed SARS-CoV-2 attachment to the cell. Huh7 cells overexpressing BTN3A2-L (BTN3A2-L Huh7) or BTN3A2-S (BTN3A2-S Huh7) and the control (Vector Huh7) cells were treated with DOX (1 μg/mL) for 24 h, then incubated with SARS-CoV-2 (MOI = 1) on ice at 4 °C for 1 h. Cells were washed by PBS three times and harvested to measure viral RNA copies based on SARS-CoV-2 N gene level. b : Representative immunofluorescence images of cell–cell fusion assay showing no apparent effect of BTN3A2 overexpression (BTN3A2-L and BTN3A2-S) on syncytia formation mediated by Spike of Delta. The HEK293T cells were transfected with Spike of Delta expression vector, and the Huh7 cells were transfected with px-300 for 16 h. The transfected Huh7 and HEK293T cells were co-cultured for 20 h and harvested for immunofluorescence assays. Scale bar, 10 μm. c : BTN3A2 interacted with the SARS-CoV-2 Spike protein. HEK293T cells (1 × 10 7 ) were co-transfected with expression vector of BTN3A2 isoform (BTN3A2-L-His or BTN3A2-S-His, each 5 μg) and Spike protein (5 μg) for 48 h. Whole-cell lysates were immunoprecipitated (IP) using anti-His antibody. Immunoblotting (IB) for His (BTN3A2-L-His or BTN3A2-S-His), Spike, and Tubulin was performed using anti-His, anti-Spike, and anti-Tubulin antibodies, respectively. d : BTN3A2-L interacted with the S1 subunit but not the S2 subunit of Spike protein. Spike S1 and S2 subunits were Flag-tagged. e : Endogenous BTN3A2 interacted with the Spike S1 protein. Huh7 cells (1 × 10 8 ) were transfected with expression vector for Spike S1 protein (S1-Flag, 20 μg) or empty vector (Vector) for 36 h, then cells were treated with or without IFN-α (450 U) for 12 h. Whole-cell lysates were immunoprecipitated (IP) using anti-Flag antibody. Immunoblotting (IB) for BTN3A2, Flag (S1-Flag), and Tubulin was performed using anti- BTN3A2, anti-Flag, and anti-Tubulin antibodies, respectively. f-g : Biolayer interferometry analyses of Spike S1 protein binding to immobilized BTN3A2-L-His ( f ) and BTN3A2-S-His ( g ). Different concentrations (1 000, 500, 250, and 125 nM, corresponding to kinetic curves from top to bottom) of Spike S1 protein were used for binding to BTN3A2-L-His and BTN3A2-S-His (lacked 125 nM), respectively. h : BTN3A2-S interacted with the Flag-tagged S1 subunit of the Spike protein. i : BTN3A2 interacted with Spike RBDs of different SARS-CoV-2 variants. Procedures for IP and IB in ( d ), ( h ) and ( i ) are the same as those in ( c ). Data are representative of three independent experiments with similar results ( b – i ). ( a ) Values were presented as mean ± SD, and differences between groups were determined by comparing to the Dox-group; ANOVA with Dunnett's multiple comparisons, ∗∗∗, P < 0.001.

    Journal: eBioMedicine

    Article Title: Primate-specific BTN3A2 protects against SARS-CoV-2 infection by interacting with and reducing ACE2

    doi: 10.1016/j.ebiom.2024.105281

    Figure Lengend Snippet: BTN3A2 inhibited SARS-CoV-2 entry and interacted with Spike protein via its RBD . a : Stable expression of BTN3A2 suppressed SARS-CoV-2 attachment to the cell. Huh7 cells overexpressing BTN3A2-L (BTN3A2-L Huh7) or BTN3A2-S (BTN3A2-S Huh7) and the control (Vector Huh7) cells were treated with DOX (1 μg/mL) for 24 h, then incubated with SARS-CoV-2 (MOI = 1) on ice at 4 °C for 1 h. Cells were washed by PBS three times and harvested to measure viral RNA copies based on SARS-CoV-2 N gene level. b : Representative immunofluorescence images of cell–cell fusion assay showing no apparent effect of BTN3A2 overexpression (BTN3A2-L and BTN3A2-S) on syncytia formation mediated by Spike of Delta. The HEK293T cells were transfected with Spike of Delta expression vector, and the Huh7 cells were transfected with px-300 for 16 h. The transfected Huh7 and HEK293T cells were co-cultured for 20 h and harvested for immunofluorescence assays. Scale bar, 10 μm. c : BTN3A2 interacted with the SARS-CoV-2 Spike protein. HEK293T cells (1 × 10 7 ) were co-transfected with expression vector of BTN3A2 isoform (BTN3A2-L-His or BTN3A2-S-His, each 5 μg) and Spike protein (5 μg) for 48 h. Whole-cell lysates were immunoprecipitated (IP) using anti-His antibody. Immunoblotting (IB) for His (BTN3A2-L-His or BTN3A2-S-His), Spike, and Tubulin was performed using anti-His, anti-Spike, and anti-Tubulin antibodies, respectively. d : BTN3A2-L interacted with the S1 subunit but not the S2 subunit of Spike protein. Spike S1 and S2 subunits were Flag-tagged. e : Endogenous BTN3A2 interacted with the Spike S1 protein. Huh7 cells (1 × 10 8 ) were transfected with expression vector for Spike S1 protein (S1-Flag, 20 μg) or empty vector (Vector) for 36 h, then cells were treated with or without IFN-α (450 U) for 12 h. Whole-cell lysates were immunoprecipitated (IP) using anti-Flag antibody. Immunoblotting (IB) for BTN3A2, Flag (S1-Flag), and Tubulin was performed using anti- BTN3A2, anti-Flag, and anti-Tubulin antibodies, respectively. f-g : Biolayer interferometry analyses of Spike S1 protein binding to immobilized BTN3A2-L-His ( f ) and BTN3A2-S-His ( g ). Different concentrations (1 000, 500, 250, and 125 nM, corresponding to kinetic curves from top to bottom) of Spike S1 protein were used for binding to BTN3A2-L-His and BTN3A2-S-His (lacked 125 nM), respectively. h : BTN3A2-S interacted with the Flag-tagged S1 subunit of the Spike protein. i : BTN3A2 interacted with Spike RBDs of different SARS-CoV-2 variants. Procedures for IP and IB in ( d ), ( h ) and ( i ) are the same as those in ( c ). Data are representative of three independent experiments with similar results ( b – i ). ( a ) Values were presented as mean ± SD, and differences between groups were determined by comparing to the Dox-group; ANOVA with Dunnett's multiple comparisons, ∗∗∗, P < 0.001.

    Article Snippet: To measure the cell surface expression level of ACE2, Huh7 cells and Calu-3 cells with BTN3A2 overexpression (BTN3A2-L Huh7 cells, BTN3A2-S Huh7 cells, BTN3A2-L Calu-3 cells and BTN3A2-S Calu-3 cells) or knockout (sgBTN3A2-1 Huh7 cells, sgBTN3A2-3 Huh7 cells, sgBTN3A2-1 Calu-3 cells, and sgBTN3A2-3 Calu-3 cells), and corresponding control cells (Vector Huh7, Vector Calu-3, sgNC Huh7, and sgNC Calu-3) were washed with PBS and stained with mouse anti-ACE2 (66699-1-Ig, Proteintech, China) at a 1:50 dilution for 30 min at 4 °C.

    Techniques: Expressing, Control, Plasmid Preparation, Incubation, Immunofluorescence, Cell-Cell Fusion Assay, Over Expression, Transfection, Cell Culture, Immunoprecipitation, Western Blot, Protein Binding, Binding Assay

    BTN3A2 inhibited ACE2 expression . a : Differential expression of BTN3A2 and ACE2 in scRNA-seq dataset of lung tissues from COVID-19 patients and uninfected individuals. Original dataset was reported in Melms et al. Significance was assessed by two-sided Wilcox rank sum test. b : Stable expression of BTN3A2 decreased ACE2 mRNA level in Huh7 cells. RNA was extracted from Huh7 cells overexpressing BTN3A2-L and BTN3A2-S, or control (Vector Huh7) cells (each group 1 × 10 5 cells). BTN3A2 and ACE2 mRNA levels were measured by qRT-PCR, with normalization to GAPDH . c-d : Overexpression of BTN3A2-L ( c ) and BTN3A2-S ( d ) suppressed ACE2 protein expression in HEK293T cells. Cells (5 × 10 5 ) were transfected with indicated expression vector or empty vector (each 1.25 μg) for 48 h, then harvested for western blotting. e : Dose-dependent inhibitory effect of BTN3A2-L on ACE2 protein expression. HEK293T cells (5 × 10 5 ) were transfected with indicated expression vector or empty vector (each 0.5 μg), together with increased BTN3A2-L-His (0.25, 0.50, 0.75, and 1.50 μg, with empty vector to reach a total amount of 2.5 μg of plasmid) for 48 h, then harvested for western blotting. f : Knockout of BTN3A2 increased ACE2 mRNA level in Huh7 cells. The procedure was similar to that in (b). g : Knockout of BTN3A2 promoted ACE2 protein expression in Huh7 ( upper ) and Calu-3 ( lower ) cells. h-i : Flow cytometry was conducted to show surface ACE2 in Calu-3 cells with BTN3A2 overexpression (BTN3A2-L and BTN3A2-S) or knockout (sgBTN3A2-1 and sgBTN3A2-2), together with the control cells (vector and sgNC) and unstained cells. Cell surface expression of ACE2 was measured ( h ), and quantification of mean fluorescence intensity (MFI (%), n = 3) was based on three independent experiments ( i ). j : ACE2 in BTN3A2-tg and WT mice infected with indicated AAV-GFP and AAV-hACE2. Immunoblotting for ACE2, BTN3A2, GFP, and Tubulin was performed using anti-ACE2, anti-BTN3A2, anti-GFP, and anti-Tubulin antibodies, respectively. k : Representative images of immunohistochemical staining of ACE2 and BTN3A2 in lung tissues in ( j ). Scale bar, 100 μm. Data were representative of three independent experiments with similar results ( b-k ). Values were presented as mean ± SD ( b , f , and i ). Significance was determined compared to Vector ( b and i ) or sgNC ( f and i ). ns, not significant; ∗, P < 0.05; ∗∗, P < 0.01; ANOVA with Dunnett's multiple comparisons.

    Journal: eBioMedicine

    Article Title: Primate-specific BTN3A2 protects against SARS-CoV-2 infection by interacting with and reducing ACE2

    doi: 10.1016/j.ebiom.2024.105281

    Figure Lengend Snippet: BTN3A2 inhibited ACE2 expression . a : Differential expression of BTN3A2 and ACE2 in scRNA-seq dataset of lung tissues from COVID-19 patients and uninfected individuals. Original dataset was reported in Melms et al. Significance was assessed by two-sided Wilcox rank sum test. b : Stable expression of BTN3A2 decreased ACE2 mRNA level in Huh7 cells. RNA was extracted from Huh7 cells overexpressing BTN3A2-L and BTN3A2-S, or control (Vector Huh7) cells (each group 1 × 10 5 cells). BTN3A2 and ACE2 mRNA levels were measured by qRT-PCR, with normalization to GAPDH . c-d : Overexpression of BTN3A2-L ( c ) and BTN3A2-S ( d ) suppressed ACE2 protein expression in HEK293T cells. Cells (5 × 10 5 ) were transfected with indicated expression vector or empty vector (each 1.25 μg) for 48 h, then harvested for western blotting. e : Dose-dependent inhibitory effect of BTN3A2-L on ACE2 protein expression. HEK293T cells (5 × 10 5 ) were transfected with indicated expression vector or empty vector (each 0.5 μg), together with increased BTN3A2-L-His (0.25, 0.50, 0.75, and 1.50 μg, with empty vector to reach a total amount of 2.5 μg of plasmid) for 48 h, then harvested for western blotting. f : Knockout of BTN3A2 increased ACE2 mRNA level in Huh7 cells. The procedure was similar to that in (b). g : Knockout of BTN3A2 promoted ACE2 protein expression in Huh7 ( upper ) and Calu-3 ( lower ) cells. h-i : Flow cytometry was conducted to show surface ACE2 in Calu-3 cells with BTN3A2 overexpression (BTN3A2-L and BTN3A2-S) or knockout (sgBTN3A2-1 and sgBTN3A2-2), together with the control cells (vector and sgNC) and unstained cells. Cell surface expression of ACE2 was measured ( h ), and quantification of mean fluorescence intensity (MFI (%), n = 3) was based on three independent experiments ( i ). j : ACE2 in BTN3A2-tg and WT mice infected with indicated AAV-GFP and AAV-hACE2. Immunoblotting for ACE2, BTN3A2, GFP, and Tubulin was performed using anti-ACE2, anti-BTN3A2, anti-GFP, and anti-Tubulin antibodies, respectively. k : Representative images of immunohistochemical staining of ACE2 and BTN3A2 in lung tissues in ( j ). Scale bar, 100 μm. Data were representative of three independent experiments with similar results ( b-k ). Values were presented as mean ± SD ( b , f , and i ). Significance was determined compared to Vector ( b and i ) or sgNC ( f and i ). ns, not significant; ∗, P < 0.05; ∗∗, P < 0.01; ANOVA with Dunnett's multiple comparisons.

    Article Snippet: To measure the cell surface expression level of ACE2, Huh7 cells and Calu-3 cells with BTN3A2 overexpression (BTN3A2-L Huh7 cells, BTN3A2-S Huh7 cells, BTN3A2-L Calu-3 cells and BTN3A2-S Calu-3 cells) or knockout (sgBTN3A2-1 Huh7 cells, sgBTN3A2-3 Huh7 cells, sgBTN3A2-1 Calu-3 cells, and sgBTN3A2-3 Calu-3 cells), and corresponding control cells (Vector Huh7, Vector Calu-3, sgNC Huh7, and sgNC Calu-3) were washed with PBS and stained with mouse anti-ACE2 (66699-1-Ig, Proteintech, China) at a 1:50 dilution for 30 min at 4 °C.

    Techniques: Expressing, Control, Plasmid Preparation, Quantitative RT-PCR, Over Expression, Transfection, Western Blot, Knock-Out, Flow Cytometry, Fluorescence, Infection, Immunohistochemical staining, Staining